EuroEyes International Eye Clinic (HKSE:01846) ROCE %: 6.05% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:01846 EuroEyes International Eye Clinic Ltd HKSE:01846
79 GF Score
Price HK$2.48
GF Value HK$5.54
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is EuroEyes International Eye Clinic ROCE %?

EuroEyes International Eye Clinic HKSE:01846 79 ROCE % is 6.05% as of Dec. 2025. GuruFocus rates HKSE:01846 with a GF Score™ of 79/100 and a GF Value™ of HK$5.54 (Significantly Undervalued). The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. EuroEyes International Eye Clinic's annualized ROCE % for the quarter that ended in Dec. 2025 was 6.05%.


EuroEyes International Eye Clinic  (HKSE:01846) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


EuroEyes International Eye Clinic ROCE % Related Terms


EuroEyes International Eye Clinic ROCE % Historical Data

* Premium members only.

The historical data trend for EuroEyes International Eye Clinic's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EuroEyes International Eye Clinic ROCE % Chart

EuroEyes International Eye Clinic Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.83 10.45 13.53 9.01 7.16

EuroEyes International Eye Clinic Semi-Annual Data
Dec16 Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.44 9.77 8.21 8.18 6.05
HKSE:01846
79GF Score
EuroEyes International Eye Clinic Ltd HKSE:01846
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EuroEyes International Eye Clinic ROCE % Calculation

EuroEyes International Eye Clinic's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=111.71/( ( (1599.435 - 152.175) + (1952.235 - 278.388) )/ 2 )
=111.71/( (1447.26+1673.847)/ 2 )
=111.71/1560.5535
=7.16 %

EuroEyes International Eye Clinic's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=98.912/( ( (1811.81 - 213.795) + (1952.235 - 278.388) )/ 2 )
=98.912/( ( 1598.015 + 1673.847 )/ 2 )
=98.912/1635.931
=6.05 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 6.05% mean?
EuroEyes International Eye Clinic (HKSE:01846) has a ROCE % of 6.05% as of Dec. 2025.
Is EuroEyes International Eye Clinic's ROCE % too high?
EuroEyes International Eye Clinic's current ROCE % is 6.05%. The Healthcare Providers & Services industry median ROCE % is 6.36. EuroEyes International Eye Clinic's value of 6.05% is 4.9% below this industry median. Overall, EuroEyes International Eye Clinic has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does EuroEyes International Eye Clinic's ROCE % compare to HCA and THC?
EuroEyes International Eye Clinic's ROCE % of 6.05% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.36. EuroEyes International Eye Clinic's value of 6.05% is 4.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.36, based on 643 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EuroEyes International Eye Clinic's current ROCE % of 6.05% is 4.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EuroEyes International Eye Clinic's current ROCE % is 6.05%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EuroEyes International Eye Clinic stock overvalued right now?
Based on GuruFocus' analysis, EuroEyes International Eye Clinic (HKSE:01846) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$5.54, compared to a current price of HK$2.48 — trading 55.2% below its estimated fair value. The current ROCE % is 6.05% and 4.9% below the Healthcare Providers & Services industry median of 6.36. EuroEyes International Eye Clinic's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For EuroEyes International Eye Clinic (HKSE:01846), the current ROCE % is 6.05% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is EuroEyes International Eye Clinic (HKSE:01846) Overvalued in 2026?

Based on GuruFocus' analysis, EuroEyes International Eye Clinic stock appears to be undervalued. The current stock price of HK$2.48 is trading 55.2% below its estimated GF Value™ of HK$5.54. GuruFocus considers EuroEyes International Eye Clinic to be Significantly Undervalued.

Key valuation signals for HKSE:01846:

  • ROCE %: 6.05%
  • GF Value™: HK$5.54 vs. price of HK$2.48 (55.2% below fair value)
  • GF Score™: 79/100 with 5 warning signs
  • Industry Position: 4.9% below the Healthcare Providers & Services median

No single metric tells the full story. See the HKSE:01846 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


EuroEyes International Eye Clinic Business Description

Address Valentinskamp 90, Hamburg, DEU, 20355
EuroEyes International Eye Clinic Ltd is principally engaged in the provision of vision correction services in Germany, Denmark, the UK, the PRC including Hong Kong, and Switzerland. The Group is a high-end vision correction service provider in Germany, PRC, the UK, Denmark, and Switzerland. Its vision correction services include refractive laser surgery, phakic lens surgery (ICL), lens exchange surgery, and others including PRK/LASEK and ICRS implantation. Its revenue categories include provision of vision correction services generate maximum revenue, training services, sales of pharmaceutical products and others. The Group's five reportable segments are Germany generate maximum revenue, Denmark, UK, Chinese Mainland, and Switzerland.
79GF Score

Get the complete analysis for HKSE:01846

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$2.48
Price
HK$5.54
GF Value